Eplerenone Observational Study Of Safety And Efficacy Evaluation To Normalize Blood Pressure For Clinical Effectiveness

Trial Profile

Eplerenone Observational Study Of Safety And Efficacy Evaluation To Normalize Blood Pressure For Clinical Effectiveness

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jan 2014

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Hypertension
  • Focus Adverse reactions
  • Acronyms ESSENCE
  • Sponsors Pfizer
  • Most Recent Events

    • 15 Jan 2013 Planned End Date changed from 1 Oct 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Aug 2012 Planned end date changed from 1 Jun 2013 to 1 Oct 2012 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top